Form 4 Integrated Biopharma Inc For: 25 June
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Integrated Biopharma Inc (INBP)
Integrated Biopharma Inc stock price live, this page displays OTC INBP stock exchange data. View the INBP premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Integrated Biopharma Inc real time stock price chart below.
What Is the Integrated Biopharma Inc Stock Price Today?
The Integrated Biopharma Inc stock price today is 0.1647.
What Is the Stock Symbol for Integrated Biopharma Inc?
The stock symbol for Integrated Biopharma Inc is "INBP."
What Stock Exchange Does Integrated Biopharma Inc Trade On?
Integrated Biopharma Inc is listed and trades on the OTC Markets stock exchange.
Is Integrated Biopharma Inc a Good Stock to Buy?
Determining whether Integrated Biopharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the INBP quote. (ISIN: US45811V1052)
What Is the Integrated Biopharma Inc Stock Price Today?
The Integrated Biopharma Inc stock price today is 0.1647.
What Is the Stock Symbol for Integrated Biopharma Inc?
The stock symbol for Integrated Biopharma Inc is "INBP."
What Stock Exchange Does Integrated Biopharma Inc Trade On?
Integrated Biopharma Inc is listed and trades on the OTC Markets stock exchange.
Is Integrated Biopharma Inc a Good Stock to Buy?
Determining whether Integrated Biopharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the INBP quote. (ISIN: US45811V1052)
OTC Markets
Currency in USD
0.1647
-0.0054(-3.17%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.1647
0.1711
52 wk Range
0.1375
0.4199
INBP is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.16470.1711
52 wk Range
0.13750.4199
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
INBP Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low Price / Book multiple
- Form 10Q INTEGRATED BIOPHARMA INC For: 11 February
- Investing.com
- Form 8K INTEGRATED BIOPHARMA For: 8 May
- Investing.com
- Form 8K INTEGRATED BIOPHARMA For: 11 February
- Investing.com
- Form 8K INTEGRATED BIOPHARMA For: 15 April
- Investing.com
- Form 4 Integrated Biopharma Inc For: 25 June
- Investing.com
- Form 8K INTEGRATED BIOPHARMA For: 8 May
- Investing.com
- Form 8K INTEGRATED BIOPHARMA For: 15 April
- Investing.com
- Form 10Q INTEGRATED BIOPHARMA INC For: 11 February
- Investing.com
- Form 8K INTEGRATED BIOPHARMA For: 11 February
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Earnings
Latest Release
May 08, 2026
EPS / Forecast
-0.03 / --
Revenue / Forecast
10.11M / --
Compare INBP to Peers and Sector
Metrics to compare | INBP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipINBPPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.1x | 11.7x | 11.5x | |
PEG Ratio | 0.01 | −0.95 | 0.03 | |
Price/Book | 0.3x | 1.4x | 1.5x | |
Price / LTM Sales | 0.1x | 0.5x | 0.9x | |
Upside (Analyst Target) | - | 47.4% | 26.2% | |
Fair Value Upside | Unlock | 7.0% | 14.2% | Unlock |
Integrated BioPharma, Inc., together with its subsidiaries, engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. The company operates through two segments, Contract Manufacturing and Other Business Lines. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment provides warehousing and fulfilment services; and distributes raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Integrated Biopharma (INBP) Stock Price Today?
The Integrated Biopharma stock price today is 0.1647 USD.
What Stock Exchange Does Integrated Biopharma Trade On?
Integrated Biopharma is listed and trades on the OTC Markets.
What Is the Stock Symbol for Integrated Biopharma?
The stock symbol for Integrated Biopharma is "INBP."
What Is the Integrated Biopharma Market Cap?
As of today, Integrated Biopharma market cap is 5.1100M USD.
What Is Integrated Biopharma's Earnings Per Share (TTM)?
The Integrated Biopharma EPS (TTM) is -0.0534.
From a Technical Analysis Perspective, Is INBP a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Integrated Biopharma Stock Split?
Integrated Biopharma has split 1 times.
How Many Employees Does Integrated Biopharma Have?
Integrated Biopharma has 153 employees.
What is the current trading status of Integrated Biopharma (INBP)?
As of Jul 12, 2026, Integrated Biopharma (INBP) is trading at a price of 0.1647 USD, with a previous close of 0.1647 USD. The stock has fluctuated within a day range of 0.1647 USD to 0.1711 USD, while its 52-week range spans from 0.1375 USD to 0.4199 USD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.